24小时热门版块排行榜    

CyRhmU.jpeg
查看: 517  |  回复: 1

hht666

金虫 (正式写手)

[交流] 【讨论】Nanodiamonds Fight Cancer已有1人参与

http://pubs.acs.org/cen/news/89/i11/8911notw3.html
Faceted nanoparticles shaped somewhat like cut diamonds not only can deliver drugs to tumor cells but also can ensure that the small molecules stick around long enough to do some good, a research team has found (Sci. Trans. Med., DOI: 10.1126/scitranslmed.3001713).

Chemotherapy often fails because cells protect themselves by pumping out foreign substances via transmembrane transporter proteins. As a result, physicians have to administer cancer therapeutics at high, and sometimes harmful, concentrations for them to be efficacious.

Nanoparticles—materials that can’t as easily be kicked out of cells and can hold high concentrations of bound molecules—show promise as drug delivery vehicles. The 2- to 8-nm-diameter 
carbon-based nanodiamonds, in particular, “have unique electrostatic properties that promote potent binding of drugs” and are ideal for chemotherapy, says Dean Ho, the research team’s leader and a biomedical engineering professor at Northwestern University.

By binding the cancer agent doxorubicin to nanodiamonds, Ho and his team demonstrated particle-mediated delivery of the drug to both liver and mammary gland tumor cells in mice. In both cases, seven days after injection, the drug-loaded nanodiamonds killed about three times as many tumor cells as doxorubicin alone. They also circulated in the blood of the mice 10 times as long as the unbound cancer agent.

When treated with a high dose (200 µg) of doxorubicin, mice riddled with mammary gland tumors died after 15 days. But those treated with an equivalent dose of a nanodiamond-doxorubicin complex , which is thought to release the drug slowly over time, had a nearly 100% survival rate over the course of the eight-week study, and their tumors decreased in size by about 50%.

“What is new and striking” about this work, says Fuyu Tamanoi, a biochemist at the University of California, Los Angeles, is that the nanodiamond-doxorubicin formulation blocks tumor growth in the mice with drug-resistant mammary gland tumors cells. “This suggests that nanodiamonds can overcome drug resistance,” he says.


我给作者 发了邮件,表示我的看法 I have some questions:
           1  Nanodiamonds (carbon)  is  inert and hardly degradable in body. Would it cause some damage to   patient   ?
          2 Will you consider apply some biodegradable   material to combine with drug,such as PLA, PGA  ?  
   没有得到教授回复,也许我的问题不值一提。
  各位有空的话,可以发表点看法,十分感谢。
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zhychen2008

至尊木虫 (著名写手)


小木虫(金币+0.5):给个红包,谢谢回帖交流
现在做的大部分都停留在实验室阶段,具体对人的伤害还难以预料
Yesterday.Today,Tomorrow!
2楼2011-03-21 23:29:54
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 hht666 的主题更新
普通表情 高级回复(可上传附件)
信息提示
请填处理意见